TTRX
Turn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.74
+1.61%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1304.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 474.82x
- Price / sales
- —
- Price / cash flow
- -75.48x
Enterprise value
- Enterprise value
- $322.0M
- EV / sales
- —
- EV / EBITDA
- -77.26x
- EV / EBIT
- -46.12x
- Market cap
- $326.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026